Table 2.
Effect of Maternal Drug Treatment in Survival of 17.5 dpc Homozygous Embryos
| Drug | Treatment | Genotype of Breeding Pair | No. of Embryos | Genotype of Living Embryos at 17.5 dpc (%) (+/+)/(+/−)/(−/−) |
|---|---|---|---|---|
| No treatment | No | WT | 56 | 100/0/0 |
| No treatment | No | HE | 35 | 34/60/6 |
| ICI1 | 1.5 mg/12 d | WT | 72 | 100/0/0 |
| ICI1 | 1.5 mg/12 d | HE | 69 | 37/57/5 |
| Progesterone | 5 mg/12 d | WT | 52 | 100/0/0 |
| Progesterone | 5 mg/12 d | HE | 63 | 39/56/6 |
| Placebo | No | WT | 52 | 100/0/0 |
| Placebo | No | HE | 71 | 35/58/7 |
The number of pregnant females used for analyses was from five to eight. All data are presented as mean ±sd. dpc, Days post coitus.
ICI 182,780.